Invention Grant
US08962268B2 Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)
有权
确定患有非小细胞肺癌（NSCLC）患者生存预后的方法
- Patent Title: Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)
- Patent Title (中): 确定患有非小细胞肺癌（NSCLC）患者生存预后的方法
-
Application No.: US13138849Application Date: 2010-04-12
-
Publication No.: US08962268B2Publication Date: 2015-02-24
- Inventor: Richard De Wijn , Robby Ruijtenbeek , Maria Helena Hilhorst
- Applicant: Richard De Wijn , Robby Ruijtenbeek , Maria Helena Hilhorst
- Applicant Address: NL 's-Hertogenbosch
- Assignee: Pamgene B.V.
- Current Assignee: Pamgene B.V.
- Current Assignee Address: NL 's-Hertogenbosch
- Agency: Amster, Rothstein & Ebenstein LLP
- Priority: EP09157816 20090410
- International Application: PCT/EP2010/054763 WO 20100412
- International Announcement: WO2010/115997 WO 20101014
- Main IPC: G01N33/00
- IPC: G01N33/00 ; C12Q1/48 ; G01N33/574 ; G01N33/48 ; C40B30/06 ; C40B30/08
Abstract:
The present invention relates to a method for determining the survival prognosis of patients suffering from non-small cell lung cancer. More specifically, the present invention provides methods which measure kinase activity by studying phosphorylation levels in response to a kinase inhibitor and profiles in samples obtained from patients diagnosed with non-small cell lung cancer. The present invention also provides methods for predicting the response of a patient diagnosed with non-small cell lung cancer to a medicament.
Public/Granted literature
- US20130017963A1 METHOD FOR DETERMINING SURIVIVAL PROGNOSIS OF PATIENTS SUFFERING FROM NON-SMALL CELL LUNG CANCER (NSCLC) Public/Granted day:2013-01-17
Information query
